C. Slabber - Concepedia

Author

C. Slabber

Also Known As

Bernardo Rapoport, C F Slabber, C Slabber, C. F. Slabber, C. Slabber, C.F. Slabber, Coenraad F Slabber, Coenraad F. Slabber, Coenraad Frederik Slabber, Coenraad Slabber

Publications

504

Citations

H-Index

Concepts

All Affiliations

University of Pretoria Life Groenkloof Hospital The Medical Oncology Centre of Rosebank

About

C. Slabber is an author at University of Pretoria specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	367
2	Pathology	2	2	64
3	Health Sciences	1	1	84
4	Immunology	1	1	17
5	Pharmacology	1	1	47

C. Slabber

Publications

454

Citations

H-Index

Page 1

	Year	Citations
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning, Annals of Oncology Venous DiseaseOncologyVenous ThrombosisCentral Venous CathetersPatient Safety	2005	219
A Randomized Study of Radiotherapy Alone Versus Radiotherapy Plus 5-Fluorouracil and Platinum in Patients With Inoperable, Locally Advanced Squamous Cancer of the Esophagus C. Slabber, Johan S. Nel, L. Schoeman, American Journal of Clinical Oncology Squamous Cell CancerSurgical OncologyEsophagusWeight LossRadiation Therapy	1998	84
The <scp>RNA</scp> helicase <scp>DHX</scp> 9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation Sergio Leone, Dominik Bär, C. Slabber, EMBO Reports	2017	52
First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study Daniel Vorobiof, Bernardo L. Rapoport, Martin Chasen, The Breast Metastatic Breast CancerOncologyBreast OncologyDurable Response RateMedicine	2004	47
Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer Bernardo L. Rapoport, Daniel Vorobiof, C. Slabber, International Journal of Gynecological Cancer	2009	22
13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: A phase II trial C. Slabber, Geoffrey Falkson, W. Burger, Investigational New Drugs Advanced Esophageal CancerEsophageal CancerPhase Ii TrialMedicineImmunology	1996	17
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis Abbie E. Fearon, C. Slabber, Andrii Kuklin, iScience	2021	13

Page 1